[en] OBJECTIVE: To determine the impact of methicillin-resistant Staphylococcus aureus (MRSA) colonization on the occurrence of S. aureus infections (methicillin-resistant and methicillin-susceptible), the use of glycopeptides, and outcome among intensive care unit (CU) patients.
DESIGN: Prospective observational cohort survey.
SETTING: A medical-surgical ICU with 10 single-bed rooms in a 460-bed, tertiary-care, university-affiliated hospital.
PATIENTS: A total of 1,044 ICU patients were followed for the detection of MRSA colonization from July 1, 1995, to July, 1 1998.
METHODS: MRSA colonization was detected using nasal samples in all patients plus wound samples in surgical patients within 48 hours of admission or within the first 48 hours of ICU stay and weekly thereafter. MRSA infections were defined using Centers for Disease Control and Prevention standard definitions, except for ventilator-associated pneumonia and catheter-related infections, which were defined by quantitative distal culture samples.
RESULTS: One thousand forty-four patients (70% medical patients) were included in the analysis. Mean age was 61+/-18 years; mean Simplified Acute Physiologic Score (SAPS) II was 36.4+/-20; and median ICU stay was 4 (range, 1-193) days. Two hundred thirty-one patients (22%) died in the ICU. Fifty-four patients (5.1%) were colonized with MRSA on admission, and 52 (4.9%) of 1,044 acquired MRSA colonization in the ICU. Thirty-five patients developed a total of 42 S. aureus infections (32 MRSA, 10 methicillin-susceptible). After factors associated with the development of an S. aureus infection were adjusted for in a multivariate Cox model (SAPS II >36: hazard ratio [HR], 1.64; P=.09; male gender: HR, 2.2; P=.05), MRSA colonization increased the risk of S. aureus infection (HR, 3.84; P=.0003). MRSA colonization did not influence ICU mortality (HR, 1.01; P=.94). Glycopeptides were used in 11.4% of the patients (119/1,044) for a median duration of 5 days. For patients with no colonization, MRSA colonization on admission, and ICU-acquired MRSA colonization, respectively, glycopeptide use per 1,000 hospital days was 37.7, 235.2, and 118.3 days. MRSA colonization per se increased by 3.3-fold the use of glycopeptides in MRSA-colonized patients, even when an MRSA infection was not demonstrated, compared to non-colonized patients.
CONCLUSIONS: In our unit, MRSA colonization greatly increased the risk of S. aureus infection and of glycopeptide use in colonized and non-colonized patients, without influencing ICU mortality. MRSA colonization influenced glycopeptide use even if an MRSA infection was not demonstrated; thus, an MRSA control program is warranted to decrease vancomycin use and to limit glycopeptide resistance in gram-positive cocci.
Disciplines :
Anesthesia & intensive care
Author, co-author :
Garrouste-Orgeas, Maité; Service de Réanimation Polyvalente, Hĵpital Saint Joseph, Paris, France
Timsit, Jean-Francois
Kallel, Hatem
Ben Ali, A
Dumay, Marie Francoise
Paoli, Benedicte
Misset, Benoît ; Centre Hospitalier Universitaire de Liège - CHU > > Service des soins intensifs
Carlet, Jean
Language :
English
Title :
Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbidity, mortality, and glycopeptide use.
Quincampoix J.C., Carbonne A., Loyer D., Kitzis M.D., Coutrot A., Timsit J.F. (1997) Follow up of a nosocomial outbreak of methicillin-resistant strains of Staphylococcus aureus (MRSA) with decreased susceptibility to teicoplanin (DST). 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, October; Toronto, Ontario, Canada. Abstract C-167; .
Smith T.L., Pearson M.L., Wilcox K.R., Cosme Cruz P.H., Lancaster M.V., Robinson-Dunn B. (1999) Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 340:493-501.
Sieradkzi K., Roberts R.B., Haber S.W., Tomasz A. (1999) The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N Engl J Med 340:517-523.
Vincent J.L., Bihari D.J., Suter P.M., Bruining H.A., White J., Nicolas-Chanoin M.H. (1995) The prevalence of nosocomial infection in intensive care units in Europe: Results of the European Prevalence of Infection in Intensive Care (EPIC) study. JAMA , EPIC International Advisory Committee; 274:639-644.
Le Gall J.R., Lemeshow S., Saulnier F. (1993) A new Simplified Acute Physiologic Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957-2963.
Chastre J., Fagon J.Y., Bornet-Lesco M.L., Calvat S., Dombret M.C., Al Khani R. (1995) Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med 152:231-240.
Timsit J.F., Misset B., Goldstein F.W., Carlet J. (1995) Reappraisal of distal diagnostic testings in the diagnosis of nosocomial pneumonia. Chest 108:1632-1639.
Brun-Buisson C., Abroug F., Legrand R. (1987) Diagnosis of central venous catheter-related infection: Critical level of quantitative tip cultures. Arch Intern Med 47:873-877.
Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., Hughes J.M. (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128-140.
(1986) Utilisation de l'indice de gravité simplifiée et du système omega. Mise à jour 1986. Réanimation Soins Intensifs Médecine Urgences , Commission d'Evaluation de la Société de Langue Fraņaise; 2:219-221.
Stamm A.M., Long M.N., Belcher B. (1993) Higher overall nosocomial infection rate because of increased attack rate of methicillin-resistant Staphylococcus aureus. Am J Infect Control 21:70-74.
Girou E., Pujade G., Legrand P., Cizeau F., Brun-Buisson C. (1999) Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 27:543-550.
Pujol M., Pena C., Pallares R., Ariza J., Ayats J., Dominguez M.A. (1996) Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 100:509-516.
Muder R.R., Brennen C., Wagener M.M., Vickers R.M., Rihs J.D., Hancock G.A. (1991) Methicillin-resistant staphylococcal colonization and infection in a long term care facility. Ann Intern Med 114:107-112.
Corbella X., Dominguez M.A., Pujol M., Ayats J., Sendra M., Pallares R. (1997) Staphylococcus aureus nasal carriage as a marker for subsequent staphylococcal infections in intensive care unit patients. Eur J Clin Microbiol Infect Dis 16:351-357.
Von Eiff C., Becker K., Machka K., Stammer H., Peters G. (2001) Nasal carriage as a source of Staphylococcus aureus bacteremia Study Group. N Engl J Med 344:11-16.
Fierobe J., Decre D., Muller C., Lucet J.C., Marmuse J.P., Mantz J. (1999) Methicillin-resistant Staphylococcus aureus as a causative agent of postoperative intra-abdominal infection: Relation to nasal colonization. Clin Infect Dis 29:1231-1238.
Bert F., Galdbart J.O., Zarrouk V., Le Mee J., Durand F., Mentre F. (2000) Association between nasal carriage of Staphylococcus aureus and infection in liver transplant recipients. Clin Infect Dis 31:1295-1298.
Kalmeijer M.D., Van Nieuwland-Bollen E., Bogaers-Hofman D., De Baere G.A. (2000) Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery. Infect Control Hosp Epidemiol 21:319-323.
Ruef C., Fanconi S., Nadal D. (1996) Sternal wound infection after heart operations in pediatric patients associated with nasal carriage of Staphylococcus aureus. J Thorac Cardiovasc Surg 112:681-686.
Knaus W.A., Zimmerman J.E., Wagner D.P., Draper E.A., Lawrence D.E. (1981) APACHE - Acute Physiologic and Chronic Health Evaluation: A physiologically based classification system. Crit Care Med 9:591-597.
Bueno-Cavanillas A., Delgado-Rodriguez M., Lopez-Luque A., Schaffino-Cano S., Galvez-Vargas R. (1994) Influence of nosocomial infection on mortality rate in an intensive care unit. Crit Care Med 22:55-60.
Reardon C.M., La H., Brown T.P., Stephenson A.J., Freedlander E. (1998) Methicillin-resistant Staphylococcus aureus in burn patients. Why all the fuss?. Burns 24:393-397.
Fridkin S.K., Edwards J.R., Pichette S.C., Pryor E.R., McGowan J.E., Tenover F.C. (1999) Determinants of vancomycin use in adult intensive care units in 41 United States hospitals. Clin Infect Dis 28:1119-1125.
Hiramatsu K., Hanaki H., Ino T., Yabuta K., Oguri T., Tenover F.C. (1997) Methicillin-resistant Staphylococcus aureus strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40:135-136.
Bhorade S.M., Christenson J., Pohlman A.S., Arnow P.M., Hall J.B. (1999) The incidence of and clinical variables associated with vancomycin-resistant enterococcal colonization in mechanically ventilated patients. Crit Care Med 115:1085-1091.
(1995) Preventing the spread of vancomycin resistance: A report from the Hospital Infection Control Practices Advisory Committee prepared by the Subcommittee on Prevention and Control of Antimicrobial-Resistant Micro-organisms in Hospitals. Infect Control Hosp Epidemiol 16:105-113.
Evans M.E., Milheim E.T., Rapp R.P. (1999) Vancomycin use in a university medical center: Effect of a vancomycin continuation form. Infect Control Hosp Epidemiol 20:417-420.
Lipsky B.A., Baker C.A., McDonald L.L., Suzuki N.T. (1999) Improving the appropriateness of vancomycin use by sequential interventions. Am J Infect Control 27:84-90.
Roghmann M.C., Perdue B.E., Polish L. (1999) Vancomycin use in a hospital with vancomycin restriction. Infect Control Hosp Epidemiol 20:60-63.
Hamilton C.D., Drew R., Janning S.W., Latour J.K., Hayward S. (2000) Excessive use of vancomycin: A successful intervention strategy at an academic medical center. Infect Control Hosp Epidemiol 21:42-45.
Monnet D.L. (1998) Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: Possible implications for control. Infect Control Hosp Epidemiol 19:552-559.
Boyce J.M. (1991) Should we vigorously try to contain and control methicillin-resistant Staphylococcus aureus?. Infect Control Hosp Epidemiol 12:46-54.
Chaix C., Durand-Zaleski I., Alberti C., Brun-Buisson C. (1999) Control of endemic methicillin-resistant Staphylococcus aureus: A cost-benefit analysis in an intensive care unit. JAMA 282:1745-1751.
Asencio A., Guerrero A., Querada C., Lizan M., Martinez-Ferrer M. (1996) Colonization and infection with methicillin-resistant Staphylococcus aureus: Associated risk factors and eradication. Infect Control Hosp Epidemiol 17:20-28.
Grundmann H. Methicillin-Resistant Staphylococcus aureus in a Teaching Hospital: Investigation of Nosocomial Transmission Using a Matched Case-Control Study, Dissertation. London, England: London School of Hygiene and Tropical Medicine; 1997.